The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Simon Langdon; Dana Faratian; Charlie Gourley; David Harrison; In Hwa Um; John Smyth

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Simon Langdon, Dana Faratian, Charlie Gourley, David Harrison, In Hwa Um, John Smyth

School of Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English
Title of host publication	Aromatase inhibitors: Types, Mode of Action and Indications
Publisher	Nova Science Pub Incorporated
Pages	163-174
Number of pages	12
ISBN (Print)	9781607417118
Publication status	Published - 2009

Publication series

Name	Cancer Etiology, Diagnosis and Treatment Series

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Langdon, S., Faratian, D., Gourley, C., Harrison, D., Um, I. H., & Smyth, J. (2009). The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. In Aromatase inhibitors: Types, Mode of Action and Indications (pp. 163-174). (Cancer Etiology, Diagnosis and Treatment Series). Nova Science Pub Incorporated.

Langdon, Simon ; Faratian, Dana ; Gourley, Charlie et al. / The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors : Aromatase inhibitors: Types, Mode of Action and Indications. Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, 2009. pp. 163-174 (Cancer Etiology, Diagnosis and Treatment Series).

@inbook{f765720b492745faaf63d6ab6ac92dbb,

title = "The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications",

author = "Simon Langdon and Dana Faratian and Charlie Gourley and David Harrison and Um, {In Hwa} and John Smyth",

note = "M1 - Chapter (peer-reviewed)",

year = "2009",

language = "English",

isbn = "9781607417118",

series = "Cancer Etiology, Diagnosis and Treatment Series",

publisher = "Nova Science Pub Incorporated",

pages = "163--174",

booktitle = "Aromatase inhibitors: Types, Mode of Action and Indications",

}

Langdon, S, Faratian, D, Gourley, C, Harrison, D , Um, IH & Smyth, J 2009, The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. in Aromatase inhibitors: Types, Mode of Action and Indications. Cancer Etiology, Diagnosis and Treatment Series, Nova Science Pub Incorporated, pp. 163-174.

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. / Langdon, Simon; Faratian, Dana; Gourley, Charlie et al.
Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated, 2009. p. 163-174 (Cancer Etiology, Diagnosis and Treatment Series).

Research output: Chapter in Book/Report/Conference proceeding › Chapter

TY - CHAP

T1 - The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors

T2 - Aromatase inhibitors: Types, Mode of Action and Indications

AU - Langdon, Simon

AU - Faratian, Dana

AU - Gourley, Charlie

AU - Harrison, David

AU - Um, In Hwa

AU - Smyth, John

N1 - M1 - Chapter (peer-reviewed)

PY - 2009

Y1 - 2009

UR - http://books.google.co.uk/books?id=YXRyPgAACAAJ

M3 - Chapter

SN - 9781607417118

T3 - Cancer Etiology, Diagnosis and Treatment Series

SP - 163

EP - 174

BT - Aromatase inhibitors: Types, Mode of Action and Indications

PB - Nova Science Pub Incorporated

ER -

Langdon S, Faratian D, Gourley C, Harrison D , Um IH, Smyth J. The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications. In Aromatase inhibitors: Types, Mode of Action and Indications. Nova Science Pub Incorporated. 2009. p. 163-174. (Cancer Etiology, Diagnosis and Treatment Series).

The use of aromatase inhibitors in ovarian cancer and identification of responsive tumors: Aromatase inhibitors: Types, Mode of Action and Indications

Publication series

UN SDGs

Other files and links

Cite this